Probing The Realities of Big Data In Alzheimer's

This blog post was originally published by the Huffington Post. - Trish Still Alice , the film with Academy-award winning actress Julianne Moore, powerfully depicts a woman's steep descent into Alzheimer's Disease (AD) and demonstrates why people overwhelmingly cite Alzheimer's as the disease they most fear. There is currently no effective treatment for AD. For individuals, an Alzheimer's diagnosis is the beginning of a dark, inevitable journey to a place where our connection to ourselves and the world slowly fades away. For governments, the spiraling global growth of the disease -- with nearly 150 million victims projected for 2050 --

What Seth Rogen Can Teach Silicon Valley About Alzheimer's

For Alzheimer's, the old Dickensian paradox holds: we are in the best of times and the worst. Times are bad because there is no effective way to treat or prevent Alzheimer's, and global rates of the disease are going to double by 2030 and reach 135 million by mid-century . Families are financially and emotionally devastated by the disease, and national budgets are becoming overwhelmed by the disease's extraordinary costs. And even though Alzheimer's is a greater burden than cancer, diabetes, and other age-related non-communicable diseases, only rarely does Alzheimer's receive adequate attention. But times are also good. The fight

Alzheimer's Summit: Some Rare Good News

Editor's note: this blog post originally appeared on Huffington Post 50 It's been a tough couple of months for American healthcare. The sequester - blunt and arbitrary policy that it is - has paralyzed funding for basic medical research. And the launch of the Affordable Care Act has been, depending on your political persuasion, anything from a technical start-up glitch to a predictable debacle. Indeed, the road to improving medicine and healthcare in the latter half of 2013 has been filled with bumps and potholes. Yet, behind the noise, there are signals that a unified effort is arising to tackle

The Government Shut Down, But Alzheimer's Did Not

Editor's note: this blog post originally appeared on Huffington Post 50 For a tormenting two weeks, the fiscal future of the U.S. seemed to hang in the balance on Capitol Hill. The world's eyes were glued to the Legislative Branch as disagreements boiled into feuds and gave way to iron-fisted gridlock. Markets sputtered. Talking heads excoriated. And while liberal and conservative media outlets disagree on the political consequences, there's a bigger issue no one's talking about: federal research lost. And it looks like it will keep losing. When the government re-opened, it failed to address the arbitrary, across-the-board sequester that

How Blue Button Can Help Caregivers and Beat Alzheimer's

Editor's note: This blog post originally appeared on The Huffington Post It's one of this century's most glaring paradoxes. You can do almost anything on your smart phone -- buy a book, find a taxi, manage your investment portfolio, watch a Yankees game while in Mogadishu -- but you can't get to your health records. The Internet, great disruptive force that it is, can't penetrate the wall between you and your own health information siloed away in your doctors' files. Remember the days, decades ago, when email systems in different companies couldn't speak to each other? It seems like ancient